50.47
price up icon1.43%   0.71
after-market アフターアワーズ: 51.00 0.53 +1.05%
loading
前日終値:
$49.76
開ける:
$49.97
24時間の取引高:
1.74M
Relative Volume:
0.63
時価総額:
$61.97B
収益:
$48.62B
当期純損益:
$6.80B
株価収益率:
18.00
EPS:
2.8038
ネットキャッシュフロー:
$7.62B
1週間 パフォーマンス:
+2.23%
1か月 パフォーマンス:
-5.04%
6か月 パフォーマンス:
+4.15%
1年 パフォーマンス:
+1.94%
1日の値動き範囲:
Value
$49.96
$50.56
1週間の範囲:
Value
$48.70
$50.56
52週間の値動き範囲:
Value
$45.80
$60.12

Sanofi Adr Stock (SNY) Company Profile

Name
名前
Sanofi Adr
Name
セクター
Healthcare (1171)
Name
電話
-
Name
住所
-
Name
職員
82,878
Name
Twitter
@sanofi
Name
次回の収益日
2024-10-25
Name
最新のSEC提出書
Name
SNY's Discussions on Twitter

SNY を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - General icon
SNY
Sanofi Adr
50.47 127.40B 48.62B 6.80B 7.62B 2.8038
Drug Manufacturers - General icon
LLY
Lilly Eli Co
769.88 648.68B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
155.03 369.52B 89.33B 21.81B 18.57B 8.99
Drug Manufacturers - General icon
ABBV
Abbvie Inc
189.83 327.88B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
74.63 308.64B 43.59B 15.04B 10.74B 3.3766
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
118.02 222.36B 53.22B 12.86B 14.85B 6.39

Sanofi Adr Stock (SNY) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-15 開始されました Exane BNP Paribas Outperform
2025-03-21 開始されました Goldman Neutral
2025-01-30 アップグレード Deutsche Bank Sell → Hold
2024-07-26 繰り返されました Argus Buy
2024-01-23 開始されました Morgan Stanley Equal-Weight
2024-01-16 再開されました UBS Buy
2023-12-05 ダウングレード JP Morgan Overweight → Neutral
2023-10-30 ダウングレード Stifel Buy → Hold
2023-09-06 アップグレード Berenberg Hold → Buy
2023-07-14 開始されました HSBC Securities Buy
2023-04-28 ダウングレード Deutsche Bank Hold → Sell
2023-03-27 アップグレード Barclays Equal Weight → Overweight
2022-12-13 再開されました Morgan Stanley Overweight
2022-08-12 アップグレード Deutsche Bank Sell → Hold
2022-08-09 ダウングレード UBS Buy → Neutral
2022-05-23 開始されました SVB Leerink Outperform
2021-09-27 アップグレード SVB Leerink Mkt Perform → Outperform
2021-01-15 開始されました Deutsche Bank Sell
2020-09-29 開始されました Berenberg Hold
2020-03-17 アップグレード Barclays Underweight → Equal Weight
2020-03-11 アップグレード Goldman Neutral → Buy
2020-02-11 開始されました SVB Leerink Mkt Perform
2020-01-06 アップグレード JP Morgan Neutral → Overweight
2019-09-23 アップグレード Guggenheim Neutral → Buy
2019-09-20 アップグレード Morgan Stanley Equal-Weight → Overweight
2019-09-03 開始されました Bernstein Outperform
2019-08-14 アップグレード UBS Neutral → Buy
2018-12-11 アップグレード Jefferies Hold → Buy
2018-11-01 アップグレード Barclays Underweight → Equal Weight
2018-10-09 開始されました Guggenheim Neutral
2018-09-10 アップグレード BofA/Merrill Neutral → Buy
2018-08-10 アップグレード Citigroup Neutral → Buy
2018-03-23 アップグレード Liberum Hold → Buy
2018-01-23 ダウングレード Barclays Equal Weight → Underweight
2017-12-06 ダウングレード BofA/Merrill Buy → Neutral
2017-12-01 ダウングレード Morgan Stanley Overweight → Underweight
2017-11-15 アップグレード Barclays Underweight → Equal Weight
2017-08-30 アップグレード HSBC Securities Reduce → Hold
すべてを表示

Sanofi Adr (SNY) 最新ニュース

pulisher
12:43 PM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanofi - GlobeNewswire Inc.

12:43 PM
pulisher
07:00 AM

Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025) - GlobeNewswire Inc.

07:00 AM
pulisher
Jun 02, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Jun 02, 2025
pulisher
Jun 02, 2025

France’s Sanofi to buy U.S. biopharma group Blueprint for up to $9.5-billion - The Globe and Mail

Jun 02, 2025
pulisher
Jun 02, 2025

Sanofi doubles down on immunology with $9.1bn Blueprint deal - Proactive financial news

Jun 02, 2025
pulisher
May 31, 2025

European ADR Index Slips As Pharma Stocks Buck The Trend - Finimize

May 31, 2025
pulisher
May 30, 2025

Regeneron and Sanofi: Disappointing Top-Line Results for Itepekimab From Two Phase 3 Trials - Morningstar

May 30, 2025
pulisher
May 30, 2025

Regeneron Pharmaceuticals Crashes 19% On A Surprise Sanofi-Tied Failure - Investor's Business Daily

May 30, 2025
pulisher
May 30, 2025

Market movers: Canopy Growth, Zscaler, Regeneron... - Proactive financial news

May 30, 2025
pulisher
May 30, 2025

Regeneron shares plunge after mixed COPD drug trial results - Proactive Investors

May 30, 2025
pulisher
May 29, 2025

Penicillin Market Research Report 2025 - GlobeNewswire Inc.

May 29, 2025
pulisher
May 26, 2025

Prurigo Nodularis Market - GlobeNewswire Inc.

May 26, 2025
pulisher
May 23, 2025

8MM Bronchiectasis Market Opportunity Assessment and Forecasts, 2033 - GlobeNewswire Inc.

May 23, 2025
pulisher
May 22, 2025

Dollar Stock Biotech Triples On $470 Million Sanofi Takeover - Investor's Business Daily

May 22, 2025
pulisher
May 08, 2025

Metric Deep Dive: Understanding Sanofi ADR (SNY) Through its Ratios - DWinneX

May 08, 2025
pulisher
May 02, 2025

iRhythm Technologies Inc (IRTC) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

WLK’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

BIDU’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

A Tale of Resilience: Sanofi ADR Amid Stock Market Turbulence - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Company’s Banking Stock: Dissecting a 40.08% Quarterly Revenue Decline Amid Growth - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Trip.com Group Ltd ADR (TCOM) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

CYTK’s 2023 Market Dance: Down -21.41% – Time to Invest? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

CIG’s Market Whiplash: 8.19% YTD Rise, 9.30% Rise in 30 Days - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Can Navitas Semiconductor Corp Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

LX’s 2023 Market Dance: Up 43.28% – Time to Invest? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Terex Corp (TEX) Stock: 52-Week Performance Insights and Trading Volume - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Behind Cytosorbents Corp’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Procore Technologies Inc (PCOR) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Navigating TREE Stock: LendingTree Inc Journey - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Companhia Siderurgica Nacional ADR (SID) Stock: From Low to High in 52 Weeks - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

The Future of EVgo Inc: Analyzing EVGO - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Analyzing the Impact of Earnings Reports on Sunstone Hotel Investors Inc Inc. (SHO) Price Performance - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

NVS’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Unilever plc ADR: Rising -3.90% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

TTWO’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Futu Holdings Ltd ADR (FUTU) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Stryker Corp (SYK) Stock: Navigating a Year of Volatility - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Viking Holdings Ltd’s Banking’s 100-Day Moving Average at 44.43: Will the Stock Break Through? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

CTRE’s Market Whiplash: 5.78% YTD Rise, 0.22% Rise in 30 Days - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Sandisk Corp (SNDK) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

LSCC: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Canadian National Railway Co: Navigating Market Fluctuations with a 62.62B Market Cap - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

DUOL’s 2023 Market Dance: Up 43.43% – Time to Invest? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

CF Industries Holdings Inc (CF) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

PLRZ Stock: Exploring Polyrizon Ltd’s Growth - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Sumitomo Mitsui Financial Group Inc ADR (SMFG) Stock: A Year of Market Movement, Down and Up - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Vipshop Holdings Ltd ADR Inc. (VIPS) Price Performance: The Role of Supply and Demand - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Uncovering the Potential of American Homes 4 Rent (AMH) Stock - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

The Significance of Moving Averages in Live Nation Entertainment Inc Inc. (LYV) Price Performance - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

APG’s Stochastic Averages Dip: Analyzing APi Group Corporation’s Stock Performance - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

CNMD’s 52-Week Rollercoaster: From $46.00 to $78.58 – What’s Next for Investors? - investchronicle.com

May 02, 2025

Sanofi Adr (SNY) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
drug_manufacturers_general PFE
$23.35
price up icon 0.99%
$112.46
price up icon 1.81%
$290.33
price up icon 1.13%
drug_manufacturers_general GSK
$41.20
price up icon 0.12%
drug_manufacturers_general MRK
$78.97
price up icon 1.74%
drug_manufacturers_general NVS
$118.02
price up icon 0.20%
大文字化:     |  ボリューム (24 時間):